EP 1806983 B8 20090218 - NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL
Title (en)
NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL
Title (de)
NÄHRMITTEL UND/ODER PHARMAZEUTISCHES PRÄPARAT FÜR DIE PROPHYLAXE UND BEHANDLUNG VON STÖRUNGEN DER SPURENELEMENTABSORPTION AUS DEM VERDAUUNGSTRAKT
Title (fr)
PREPARATION NUTRITIVE ET/OU PHARMACEUTIQUE DESTINÉE A ETRE UTLISÉE EN PROPHYLAXIE ET TRAITEMENT DE TROUBLES DANS L' ABSORPTION DE MICRO-ELEMENTS A PARTIR DU TUBE DIGESTIF
Publication
Application
Priority
- PL 2005000068 W 20051028
- PL 37093704 A 20041029
Abstract (en)
[origin: US2009238895A1] The invention dissolves the problem of the pharmaceutical preparation being a factor stimulating the absorption of microelements. The essence of the invention is that the preparation contains alpha-keto-glutarate or/and glutamine or/and glutamate or/and ornithine of alpha-keto-glutarate, dipeptide of glutamine and other amino acids or/and tripeptides of glutamine and other amino acids or/and glutamate with other amino acid or/and salts of alpha-keto-glutarate or/and glutamine or/and glutamate or/and ornithine of alpha-keto-glutarate, dipepetides of glutamine or glutamate with other amino acid in a dose 0.01-0.5 g/kg/day and administered orally stimulates the absorption of iron, zinc, copper, manganese, strontium, calcium, phosphorus and other microelements from the alimentary canal to the blood ensuring proper-physiological-curative level of these compounds in the blood of people and animals.
IPC 8 full level
A23L 1/305 (2006.01); A23K 1/00 (2006.01); A23L 33/00 (2016.01); A61K 31/198 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); A61P 1/00 (2006.01); A61K 33/24 (2019.01)
CPC (source: EP KR US)
A23K 20/105 (2016.05 - EP US); A23K 20/142 (2016.05 - EP US); A23K 20/147 (2016.05 - EP US); A23L 33/00 (2016.08 - KR); A23L 33/175 (2016.08 - EP US); A23L 33/18 (2016.08 - EP US); A61K 31/06 (2013.01 - EP US); A61K 31/198 (2013.01 - EP US); A61K 33/24 (2013.01 - US); A61K 33/26 (2013.01 - EP US); A61K 38/05 (2013.01 - EP US); A61K 38/06 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 1/00 (2018.01 - EP); A61P 3/02 (2018.01 - EP); A61P 3/12 (2018.01 - EP); A61P 7/06 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 15/08 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 21/00 (2018.01 - EP); A61P 25/08 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/10 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61K 33/24 (2013.01 - EP)
C-Set (source: EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006046880 A1 20060504; AT E394942 T1 20080515; AU 2005300125 A1 20060504; AU 2005300125 B2 20110714; CA 2589324 A1 20060504; CN 101048081 A 20071003; CN 101048081 B 20110518; DE 602005006831 D1 20080626; EP 1806983 A1 20070718; EP 1806983 B1 20080514; EP 1806983 B8 20090218; HK 1109029 A1 20080530; JP 2008518002 A 20080529; JP 4960872 B2 20120627; KR 20070117534 A 20071212; PL 370937 A1 20060502; RU 2007115542 A 20081210; RU 2393720 C2 20100710; US 2009238895 A1 20090924
DOCDB simple family (application)
PL 2005000068 W 20051028; AT 05799655 T 20051028; AU 2005300125 A 20051028; CA 2589324 A 20051028; CN 200580037230 A 20051028; DE 602005006831 T 20051028; EP 05799655 A 20051028; HK 08103272 A 20080320; JP 2007538850 A 20051028; KR 20077011918 A 20070525; PL 37093704 A 20041029; RU 2007115542 A 20051028; US 57789205 A 20051028